000 01268 a2200361 4500
005 20250513102523.0
264 0 _c19970106
008 199701s 0 0 eng d
022 _a0892-1997
024 7 _a10.1016/s0892-1997(96)80012-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aInagi, K
245 0 0 _aAnalysis of factors affecting botulinum toxin results in spasmodic dysphonia.
_h[electronic resource]
260 _bJournal of voice : official journal of the Voice Foundation
_cSep 1996
300 _a306-13 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBotulinum Toxins
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLaryngeal Muscles
_xphysiopathology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMuscle Spasticity
_xcomplications
650 0 4 _aTreatment Outcome
650 0 4 _aVoice Disorders
_xetiology
700 1 _aFord, C N
700 1 _aBless, D M
700 1 _aHeisey, D
773 0 _tJournal of voice : official journal of the Voice Foundation
_gvol. 10
_gno. 3
_gp. 306-13
856 4 0 _uhttps://doi.org/10.1016/s0892-1997(96)80012-9
_zAvailable from publisher's website
999 _c8857893
_d8857893